The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world patient characteristics, outcomes, and resource utilization of chimeric antigen receptor (CAR) T cell therapy across Foundation for the Accreditation of Cellular Therapy (FACT) and non-FACT treatment centers in large B-cell lymphoma (LBCL).
 
Renju Raj
Honoraria - Bristol-Myers Squibb (Inst); Iovance Biotherapeutics (Inst); Kite, a Gilead Company (Inst)
Consulting or Advisory Role - Kite, a Gilead Company
Research Funding - Bristol-Myers Squibb (Inst); Iovance Biotherapeutics (Inst); Kite, a Gilead Company (Inst)
 
Timothy Beer
No Relationships to Disclose
 
Fei Fei Liu
Employment - Bristol-Myers Squibb/Celgene/Juno
Stock and Other Ownership Interests - Bristol-Myers Squibb/Celgene/Juno
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Celgene/Juno
 
Aviral Bahuguna
Stock and Other Ownership Interests - Fortis Healthcare Ltd.
Consulting or Advisory Role - GSK and BMS
 
Xiaoying Shi
No Relationships to Disclose
 
Debasmita Roy
Employment - Bristol Myers Squibb Foundation
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Christine Fu
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Yeran Li
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Lucio Gordon
Employment - Florida Cancer Specialists
Leadership - Florida Cancer Specialists
Stock and Other Ownership Interests - Core Ventures; Florida Cancer Specialists and Research Institute
Consulting or Advisory Role - Janssen Oncology
 
David Porter
Stock and Other Ownership Interests - Genentech/Roche (I)
Honoraria - Angiocrine Bioscience; Bristol-Myers Squibb/Celgene/Juno; Kite/Gilead; Mirror Biologics; Novartis; Poseida; Sana Biotechnology; Verismo
Consulting or Advisory Role - Angiocrine Bioscience; Bristol-Myers Squibb/Celgene/Juno; Kite, a Gilead company; Mirror Biologics; Novartis; Poseida; Sana Biotechnology; Verismo
Research Funding - Bristol-Myers Squibb/Celgene/Juno (Inst); Novartis
Patents, Royalties, Other Intellectual Property - Patent/royalty rights
Other Relationship - National Marrow Donor Program